TD Waterhouse Canada’s Medifast MED Stock Holding History

TD Waterhouse Canada’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-67	Closed	-$1.41K	–	1986
2024 Q2	$1.41K	Hold	67	–	–	﹤0.01%	1696
2024 Q1	$2.35K	Hold	67	–	–	﹤0.01%	1662
2023 Q4	$4.36K	Hold	67	–	–	﹤0.01%	1400
2023 Q3	$5.07K	Sell	67 -42	-39%	-$3.73K	﹤0.01%	1360
2023 Q2	$10.2K	Sell	109 -64	-37%	-$5.7K	﹤0.01%	1240
2023 Q1	$18.1K	Hold	173	–	–	﹤0.01%	1118
2022 Q4	$20.3K	Sell	173 -1,677	-91%	-$195K	﹤0.01%	1092
2022 Q3	$206K	Sell	1,850 -5,178	-74%	-$742K	﹤0.01%	662
2022 Q2	$1.29M	Buy	7,028 +2,449	+53%	+$438K	0.01%	380
2022 Q1	$809K	Sell	4,579 -239	-5%	-$45.1K	0.01%	491
2021 Q4	$1.03M	Buy	+4,818	New	+$996K	0.01%	478

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Waterhouse Canada's MED Position: Q3 2024 in Review

TD Waterhouse Canada sold out of Medifast (MED) in Q3 2024, closing a stake of 67 shares — an estimated $1.41K sold.

TD Waterhouse Canada first reported a position in MED in Q4 2021 and held it in 11 quarters. The position peaked at $1.29M in Q2 2022. 140 funds tracked by Wall St. Rank hold MED as of Q3 2024.

TD Waterhouse Canada reported no remaining Medifast position as of Q3 2024 after selling out during the quarter.
TD Waterhouse Canada sold 67 Medifast shares in Q3 2024, an estimated $1.41K.
TD Waterhouse Canada first reported a position in Medifast in Q4 2021 and held it in 11 quarters.
TD Waterhouse Canada's Medifast position peaked at $1.29M in Q2 2022.
140 funds tracked by Wall St. Rank held Medifast as of Q3 2024.

Based on TD Waterhouse Canada's 13F filing for Q3 2024, filed 12 Nov 2024.